Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Procaps Group S.A.

PROC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.01
$0.00(0.00%)
U.S. Market is Open • 12:57

Procaps Group S.A. (PROC) Stock Overview

Explore Procaps Group S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap102.1M
P/E Ratio2.40
EPS (TTM)$0.66
ROE-2.22%
Fundamental Analysis

AI Price Forecasts

1 Month$0.52
3 Months$0.59
1 Year Target$0.00

PROC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Procaps Group S.A. (PROC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 2.40 and a market capitalization of 102.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-24.06%
3-Year Change
-77.80%
5-Year Change
-90.43%
All-Time (Max) Change
-89.74%

Contact Information

https://www.procapsgroup.com
356 7995 6138
9 Rue de Bitbourg, Luxembourg City, NaN, 1273

Company Facts

55,000 Employees
IPO DateDec 9, 2019
CountryLU
Actively Trading

Frequently Asked Questions